Thinking of joining a study?

Register your interest

NCT06692374 | NOT YET RECRUITING | Cardiac Arrest (CA)


Automated Cardiac Arrest Detection and Alerting in Daily Life
Sponsor:

Radboud University Medical Center

Brief Summary:

Surviving a cardiac arrest that happens outside the hospital depends on quickly recognizing the event and immediately starting CPR. Survival rates have improved when cardiac arrest is witnessed, but when it isn't, help often arrives too late. Wearable biosensors, like special wristbands, could detect cardiac arrest automatically and alert emergency responders, providing faster help. In the already finished DETECT-1 study, the investigators developed a system that uses wrist-worn sensors to identify cardiac arrest. The goal of the current study is to test how well this system works in people who have an implantable cardioverter defibrillator (ICD). An ICD is a device that monitors and treats dangerous heart rhythms. Study participants will wear a medical wristband with sensors that monitor the heartrate and movement during their daily activities to see if the system accurately detects cardiac arrest.

Condition or disease

Cardiac Arrest (CA)

Sudden Death, Cardiac

Detailed Description:

Survival from out-of-hospital cardiac arrest (OHCA) depends on fast recognition of cardiac arrest and immediate initiation of cardiopulmonary resuscitation (CPR). While survival chances for witnessed OHCA have increased, unwitnessed cases still often receive help too late. Wearable biosensor technology with the functionality of automated cardiac arrest detection and activation of the emergency medical chain would offer a potential solution to provide early help. In the recently published DETECT-1 study, an algorithm for automated cardiac arrest detection using wrist-derived photoplethysmography (PPG) was recently developed. The current study is a prospective multicenter observational cohort study to validate the sensitivity of the developed cardiac arrest detection algorithm in patients with an implantable cardioverter defibrillator (ICD) during daily life. The study population includes patients with an ICD. Study participants will wear a medical wristband with PPG and accelerometer sensors during daily life.

Study Type : OBSERVATIONAL
Estimated Enrollment : 200 participants
Official Title : Smartwatch-based Automated Cardiac Arrest Detection and Activation of the Emergency Medical Chain: Validation in a Home Setting
Actual Study Start Date : 2025-01-01
Estimated Primary Completion Date : 2027-01-01
Estimated Study Completion Date : 2028-01-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patients with an implantable cardioverter defibrillator (ICD)
  • * Age 18 years or older
  • * Fitting the wristband
  • * In possession of a smartphone that is compatible with the wristband
Exclusion Criteria
  • * Known hemodynamically relevant bilateral subclavian artery stenosis
  • * Medical issues that interfere with wearing of the wristband (e.g. skin disorders)
  • * Insufficient skills to operate with the device/app

Automated Cardiac Arrest Detection and Alerting in Daily Life

Location Details

NCT06692374


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Netherlands, Gelderland

Radboud UMC

Nijmegen, Gelderland, Netherlands, 6525GA

Loading...